Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised double-blind placebo-controlled cross-over trial of the Polypill
2010-019874-34Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of simvastatin + losartan + amlodipine + hydrochlorothiazide in hypercholesterolemia and hypertension (HTN), sponsored by Queen Mary University of London. Primary endpoints: Placebo-adjusted change in total cholesterol, Placebo-adjusted change in LDL cholesterol and 2 more. Started Oct 2010; status: completed.
02
Drugs
simvastatin + losartan + amlodipine + hydrochlorothiazide
03
Conditions
hypercholesterolemiahypertension (HTN)
Beyond the preview
Go deeper on 2010-019874-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019874-34.